PI Pharma Insight

BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Reset

Active filters

  • Product: Eprex
Presentation Product Chemical substance Chapter Items dispensed
Eprex 10,000units/1ml inj pre-filled syringes
0901030D0BBALAL
Eprex Epoetin alfa Nutrition and Blood 33
Eprex 4,000units/0.4ml inj pre-filled syringes
0901030D0BBAKAK
Eprex Epoetin alfa Nutrition and Blood 25
Eprex 20,000units/0.5ml inj pre-filled syringes
0901030D0BBATAT
Eprex Epoetin alfa Nutrition and Blood 20
Eprex 40,000units/1ml inj pre-filled syringes
0901030D0BBAUAU
Eprex Epoetin alfa Nutrition and Blood 18
Eprex 6,000units/0.6ml inj pre-filled syringes
0901030D0BBANAN
Eprex Epoetin alfa Nutrition and Blood 14
Eprex 5,000units/0.5ml inj pre-filled syringes
0901030D0BBAMAM
Eprex Epoetin alfa Nutrition and Blood 9
Eprex 3,000units/0.3ml inj pre-filled syringes
0901030D0BBAJAJ
Eprex Epoetin alfa Nutrition and Blood 8
Eprex 8,000units/0.8ml inj pre-filled syringes
0901030D0BBAQAQ
Eprex Epoetin alfa Nutrition and Blood 4
Eprex 2,000units/0.5ml inj pre-filled syringes
0901030D0BBAIAI
Eprex Epoetin alfa Nutrition and Blood 3
Eprex 30,000units/0.75ml inj pre-filled syringes
0901030D0BBAVAV
Eprex Epoetin alfa Nutrition and Blood 3
Eprex 1,000units/0.5ml inj pre-filled syringes
0901030D0BBAHAH
Eprex Epoetin alfa Nutrition and Blood No data available
Eprex 40,000units/1ml solution for injection vials
0901030D0BBASAS
Eprex Epoetin alfa Nutrition and Blood No data available
Eprex 7,000units/0.7ml inj pre-filled syringes
0901030D0BBAPAP
Eprex Epoetin alfa Nutrition and Blood No data available
Eprex 9,000units/0.9ml inj pre-filled syringes
0901030D0BBARAR
Eprex Epoetin alfa Nutrition and Blood No data available

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.